DOCSLIB.ORG

Annual Scientific Report 2009

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Scientific Report 2009 European Bioinformatics Institute Annual Scientific Report 2009 Annual Scientific Report 2009 European Bioinformatics Institute EMBL-European Bioinformatics Institute Wellcome Trust Genome Campus, Hinxton Cambridge CB10 1SD United Kingdom Tel. +44 (0)1223 494444, Fax +44 (0)1223 494468 www.ebi.ac.uk EMBL Heidelberg Meyerhofstraße 1 69117 Heidelberg Germany Tel. +49 (0)6221 387 0, Fax +49 (0)6221 387 8306 www.embl.org info@embl.org EMBL Grenoble 6, rue Jules Horowitz, BP181 38042 Grenoble, Cedex 9 France Tel. +33 (0)4 76 20 72 69, Fax +33 (0)4 76 20 71 99 EMBL Hamburg c/o DESY Notkestraße 85 22603 Hamburg Germany Tel. +49 (0)40 89 902 110, Fax +49 (0)40 89 902 149 EMBL Monterotondo Adriano Buzzati-Traverso Campus Via Ramarini, 32 00015 Monterotondo (Rome) Italy Tel. +39 06900 91402, Fax +39 0690091406 Texts: EMBL-EBI Group and Team Leaders Layout, editing and cover design: Vienna Leigh, EMBL Office of Information and Public Affairs Louisa Wright, EMBL-EBI Outreach Programme Project Leader 3 Contents SECTION 1: INTRODUCTION 5 Foreword 7 Highlights of 2009 9 SECTION 2: SERVICES IN 2009 15 The Activities of the PANDA Group 17 The European Nucleotide Archive Team 31 Vertebrate Genomics 37 The Ensembl Genomes Team 45 The Proteomics Services Team 51 The InterPro Team 57 Computational Chemical Biology: the ChEMBL Team 61 Chemoinformatics and Metabolism 65 Database Research and Development 71 The GO Editorial Office 75 The Microarray Informatics Team 79 The Microarray Software Development Team 85 The Protein Data Bank in Europe (PDBe) Team 89 Developing and Integrating Tools for Biologists 93 Literature Resource Development 97 SECTION 3: RESEARCH IN 2009 103 The Bertone Group: differentiation and development 105 The Enright Group: functional genomics and analysis of small RNA function 111 The Goldman Group: evolutionary tools for sequence analysis 117 The Le Novère Group: computational systems neurobiology 123 The Luscombe Group: genome-scale analysis of regulatory systems 129 The Rebholz-Schuhmann Group: semantic standardisation of the scientific literature 135 The Thornton Group: computational biology of proteins 141 SECTION 4: SUPPORT IN 2009 147 Outreach and Training 149 Industry Support 159 Systems and Networking 163 External Services Team 165 4 SECTION 5: FACTS AND FIGURES 169 Services and Research 171 Publications 177 Major Database Collaborations 185 Scientific Advisory Boards 187 External Seminar Speakers 189 INDEX 191 Section 1 Introduction 5 Foreword 7 Highlights of 2009 9 6 Janet Thornton Graham Cameron Director Associate Director Foreword 7 Introduction Welcome to EMBL-EBI’s 2009 Annual Scientific Report. With the emergence of ever-more powerful sequencing and the need for improved translation of biological discover- ies into applications, EMBL-EBI’s mission, to provide bioinformatics services for biomolecular data, to perform basic bioinformatics research, to provide user training and to support industry, has never been more important. – Foreword This year has seen major developments in capturing and storing data from next-generation sequencing machines. These are powering many international projects, including the 1000 Genomes Project to reveal the molecular basis of human variation. With our international colleagues, the EBI is providing the public archive for the data generated. The computational and storage needs of all these projects are tremendous, and require an enormous growth in both the computer power and the storage needed to fulfil these commitments. This year has also seen ChEMBLdb go live. This is a freely available web resource for chemical biology and drug dis- covery research. ChEMBLdb provides worldwide access to a large number of medicinal chemistry lead optimisation experiments (usually known as Structure Activity Relationship, or SAR data) reported in the primary literature. The ChEMBLdb resource is highly complementary to existing resources such as UniProt, PDBe and ChEBI, but adds an important new capability to address the needs of the pharmaceutical and biotechnology industries, and the academic chemical biology communities with chemical data. The EBI’s research is diverse and flourishing, producing both exciting discoveries and the development of powerful new tools to handle the flood of data. We have contributed to understanding how genome structure affects its func- tion; to defining the repertoire of transcription factors, which provide regulatory mechanisms underlying biological processes in humans; and to elucidating the effect of deleting a component of the nutrient-responsive mTOR (mam- malian target of rapamycin) signalling pathway, which led to increased life span and resistance to age-related patholo- gies in mice. In parallel we have developed new resources, including leading the worldwide effort to develop a Systems Biology Graphical Notation, which is a new ‘language’ to describe and visualise all kinds of biological knowledge, from gene regulation to metabolism and cellular signalling. Our services are being used ever-more frequently by scientists in Europe and worldwide, with around 3 million web hits per day on the EBI website and over one million compute jobs per month run at the EBI. As the data resources develop, our commitment to providing training for users increases. This year we have run many new workshops and courses, both at Hinxton and throughout Europe, and participated in many conferences, in total reaching an estimated 24,000 researchers. Our Industry Programme has also grown, invigorated by the new computational chemistry devel- opments at the EBI and bringing new ideas both for services and for workshops. The Innovative Medicines Initiative (IMI), run by the European pharmaceutical industry and the European Commission, offers a welcome opportunity to address the needs of this sector more directly with explicit grant funding, involving the EBI in several new projects. The additional funding made available by EMBL Council in this indicative scheme is being used to consolidate the core set of data resources provided by EMBL-EBI, but longer-term funding is still precarious. The ELIXIR preparatory phase, which aims to develop a plan to construct and operate a sustainable infrastructure for biological information in Europe, is beginning to bear fruit. However, although two countries have already committed to this project, there is still much work to be done to define the scope and secure stable funding for this infrastructure for the future. All our efforts at the EBI rely on extensive interactions with colleagues in Europe and throughout the world. The deposition of new data, the daily exchange of information between data resources, the joint development of software tools, the sharing of curation tasks and the challenges of collaborative research have built an extensive community of collaborators. It remains our privilege and pleasure to work with them and together we will continue to aim for excel- lence in all that we do. Janet Thornton, Director Graham Cameron, Associate Director Janet Thornton, Director PhD 1973, King’s College & National Inst. For Medical Research, London. Postdoctoral research at the University of Oxford, NIMR & Birkbeck College, London. Lecturer, Birkbeck College 1983–1989. Professor of Biomolecular Structure, University College London since 1990. Bernal Professor at Birkbeck College, 1996–2002. Director of the Centre for Structural Biology at Birkbeck College and University College London, 1998–2001. Director of EMBL-EBI since 2001. 8 Graham Cameron, Associate Director Applications Programmer, EMBL Data Library, 1983–1983. Introduction Database Administrator, EMBL Data Library, 1983–1986. Manager, EMBL Data Library, 1986–1992. Project Leader overseeing the creation of EMBL-EBI Outstation, 1993–1994. Head of Services, EMBL-EBI, 1994–1998. Joint Head of EMBL-EBI, 1998–2001. – Foreword Associate Director of EMBL-EBI since 2001. Janet Thornton Graham Cameron Director Associate Director Highlights of 2009 9 SERVICES Introduction Enabling optimal exploitation of biomolecular information is at the heart of EMBL-EBI’s mission. The EBI services include the provision of biological databases and tools to explore them. Our constituency includes academic and com- mercial researchers throughout Europe and the world, and we form a European node in many global data-sharing – Highlights of 2009 collaborations (figure 1). These service activities are accompanied by extensive outreach and training (concentrated mostly in Europe) with a dedicated team (see page 149), and industry users receive targeted support through the EBI’s Industry Programme (page 159). 2009 has been an interesting year for these services. The familiar ever-increasing data flow rates perpetuate exponen- tial database growth curves, which are already etched on the retinas of service providers and funders. However, in 2009 striking qualitative changes have accompanied the familiar quantitative changes. This has resulted in new data resources, restructuring of existing resources and the demise of some obsolete resources. EMBL-Bank Ensembl Ensembl Genomes ArrayExpress UniProt InterPro IntAct PRIDE PDBe Reactome GO Figure 1. Map showing location of EMBL-EBI’s collaborations for the major databases. One of the most striking new resources is ChEMBLdb, a database of bioactive compounds (drugs and drug-like molecules) and their quantitative properties and bioactivities. Computer methods for the storage and exploitation of chemical information – now called cheminformatics – pre-date the existence
Load more

Recommended publications
  • ANNUAL REVIEW 1 October 2005–30 September
    WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health.
    [Show full text]
  • Applied Category Theory for Genomics – an Initiative
    Applied Category Theory for Genomics { An Initiative Yanying Wu1,2 1Centre for Neural Circuits and Behaviour, University of Oxford, UK 2Department of Physiology, Anatomy and Genetics, University of Oxford, UK 06 Sept, 2020 Abstract The ultimate secret of all lives on earth is hidden in their genomes { a totality of DNA sequences. We currently know the whole genome sequence of many organisms, while our understanding of the genome architecture on a systematic level remains rudimentary. Applied category theory opens a promising way to integrate the humongous amount of heterogeneous informations in genomics, to advance our knowledge regarding genome organization, and to provide us with a deep and holistic view of our own genomes. In this work we explain why applied category theory carries such a hope, and we move on to show how it could actually do so, albeit in baby steps. The manuscript intends to be readable to both mathematicians and biologists, therefore no prior knowledge is required from either side. arXiv:2009.02822v1 [q-bio.GN] 6 Sep 2020 1 Introduction DNA, the genetic material of all living beings on this planet, holds the secret of life. The complete set of DNA sequences in an organism constitutes its genome { the blueprint and instruction manual of that organism, be it a human or fly [1]. Therefore, genomics, which studies the contents and meaning of genomes, has been standing in the central stage of scientific research since its birth. The twentieth century witnessed three milestones of genomics research [1]. It began with the discovery of Mendel's laws of inheritance [2], sparked a climax in the middle with the reveal of DNA double helix structure [3], and ended with the accomplishment of a first draft of complete human genome sequences [4].
    [Show full text]
  • Ensembl Genomes: Extending Ensembl Across the Taxonomic Space P
    Published online 1 November 2009 Nucleic Acids Research, 2010, Vol. 38, Database issue D563–D569 doi:10.1093/nar/gkp871 Ensembl Genomes: Extending Ensembl across the taxonomic space P. J. Kersey*, D. Lawson, E. Birney, P. S. Derwent, M. Haimel, J. Herrero, S. Keenan, A. Kerhornou, G. Koscielny, A. Ka¨ ha¨ ri, R. J. Kinsella, E. Kulesha, U. Maheswari, K. Megy, M. Nuhn, G. Proctor, D. Staines, F. Valentin, A. J. Vilella and A. Yates EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SD, UK Received August 14, 2009; Revised September 28, 2009; Accepted September 29, 2009 ABSTRACT nucleotide archives; numerous other genomes exist in states of partial assembly and annotation; thousands of Ensembl Genomes (http://www.ensemblgenomes viral genomes sequences have also been generated. .org) is a new portal offering integrated access to Moreover, the increasing use of high-throughput genome-scale data from non-vertebrate species sequencing technologies is rapidly reducing the cost of of scientific interest, developed using the Ensembl genome sequencing, leading to an accelerating rate of genome annotation and visualisation platform. data production. This not only makes it likely that in Ensembl Genomes consists of five sub-portals (for the near future, the genomes of all species of scientific bacteria, protists, fungi, plants and invertebrate interest will be sequenced; but also the genomes of many metazoa) designed to complement the availability individuals, with the possibility of providing accurate and of vertebrate genomes in Ensembl. Many of the sophisticated annotation through the similarly low-cost databases supporting the portal have been built in application of functional assays.
    [Show full text]
  • Gene Prediction: the End of the Beginning Comment Colin Semple
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central http://genomebiology.com/2000/1/2/reports/4012.1 Meeting report Gene prediction: the end of the beginning comment Colin Semple Address: Department of Medical Sciences, Molecular Medicine Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. E-mail: Colin.Semple@ed.ac.uk Published: 28 July 2000 reviews Genome Biology 2000, 1(2):reports4012.1–4012.3 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2000/1/2/reports/4012 © GenomeBiology.com (Print ISSN 1465-6906; Online ISSN 1465-6914) Reducing genomes to genes reports A report from the conference entitled Genome Based Gene All ab initio gene prediction programs have to balance sensi- Structure Determination, Hinxton, UK, 1-2 June, 2000, tivity against accuracy. It is often only possible to detect all organised by the European Bioinformatics Institute (EBI). the real exons present in a sequence at the expense of detect- ing many false ones. Alternatively, one may accept only pre- dictions scoring above a more stringent threshold but lose The draft sequence of the human genome will become avail- those real exons that have lower scores. The trick is to try and able later this year. For some time now it has been accepted increase accuracy without any large loss of sensitivity; this deposited research that this will mark a beginning rather than an end. A vast can be done by comparing the prediction with additional, amount of work will remain to be done, from detailing independent evidence.
    [Show full text]
  • Abstracts Genome 10K & Genome Science 29 Aug - 1 Sept 2017 Norwich Research Park, Norwich, Uk
    Genome 10K c ABSTRACTS GENOME 10K & GENOME SCIENCE 29 AUG - 1 SEPT 2017 NORWICH RESEARCH PARK, NORWICH, UK Genome 10K c 48 KEYNOTE SPEAKERS ............................................................................................................................... 1 Dr Adam Phillippy: Towards the gapless assembly of complete vertebrate genomes .................... 1 Prof Kathy Belov: Saving the Tasmanian devil from extinction ......................................................... 1 Prof Peter Holland: Homeobox genes and animal evolution: from duplication to divergence ........ 2 Dr Hilary Burton: Genomics in healthcare: the challenges of complexity .......................................... 2 INVITED SPEAKERS ................................................................................................................................. 3 Vertebrate Genomics ........................................................................................................................... 3 Alex Cagan: Comparative genomics of animal domestication .......................................................... 3 Plant Genomics .................................................................................................................................... 4 Ksenia Krasileva: Evolution of plant Immune receptors ..................................................................... 4 Andrea Harper: Using Associative Transcriptomics to predict tolerance to ash dieback disease in European ash trees ............................................................................................................
    [Show full text]
  • Proquest Dissertations
    Automated learning of protein involvement in pathogenesis using integrated queries Eithon Cadag A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2009 Program Authorized to Offer Degree: Department of Medical Education and Biomedical Informatics UMI Number: 3394276 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMI Dissertation Publishing UMI 3394276 Copyright 2010 by ProQuest LLC. All rights reserved. This edition of the work is protected against unauthorized copying under Title 17, United States Code. uest ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 University of Washington Graduate School This is to certify that I have examined this copy of a doctoral dissertation by Eithon Cadag and have found that it is complete and satisfactory in all respects, and that any and all revisions required by the final examining committee have been made. Chair of the Supervisory Committee: Reading Committee: (SjLt KJ. £U*t~ Peter Tgffczy-Hornoch In presenting this dissertation in partial fulfillment of the requirements for the doctoral degree at the University of Washington, I agree that the Library shall make its copies freely available for inspection. I further agree that extensive copying of this dissertation is allowable only for scholarly purposes, consistent with "fair use" as prescribed in the U.S.
    [Show full text]
  • Molecular Biology for Computer Scientists
    CHAPTER 1 Molecular Biology for Computer Scientists Lawrence Hunter “Computers are to biology what mathematics is to physics.” — Harold Morowitz One of the major challenges for computer scientists who wish to work in the domain of molecular biology is becoming conversant with the daunting intri- cacies of existing biological knowledge and its extensive technical vocabu- lary. Questions about the origin, function, and structure of living systems have been pursued by nearly all cultures throughout history, and the work of the last two generations has been particularly fruitful. The knowledge of liv- ing systems resulting from this research is far too detailed and complex for any one human to comprehend. An entire scientific career can be based in the study of a single biomolecule. Nevertheless, in the following pages, I attempt to provide enough background for a computer scientist to understand much of the biology discussed in this book. This chapter provides the briefest of overviews; I can only begin to convey the depth, variety, complexity and stunning beauty of the universe of living things. Much of what follows is not about molecular biology per se. In order to 2ARTIFICIAL INTELLIGENCE & MOLECULAR BIOLOGY explain what the molecules are doing, it is often necessary to use concepts involving, for example, cells, embryological development, or evolution. Bi- ology is frustratingly holistic. Events at one level can effect and be affected by events at very different levels of scale or time. Digesting a survey of the basic background material is a prerequisite for understanding the significance of the molecular biology that is described elsewhere in the book.
    [Show full text]
  • The EMBL-European Bioinformatics Institute the Hub for Bioinformatics in Europe
    The EMBL-European Bioinformatics Institute The hub for bioinformatics in Europe Blaise T.F. Alako, PhD blaise@ebi.ac.uk www.ebi.ac.uk What is EMBL-EBI? • Part of the European Molecular Biology Laboratory • International, non-profit research institute • Europe’s hub for biological data, services and research The European Molecular Biology Laboratory Heidelberg Hamburg Hinxton, Cambridge Basic research Structural biology Bioinformatics Administration Grenoble Monterotondo, Rome EMBO EMBL staff: 1500 people Structural biology Mouse biology >60 nationalities EMBL member states Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom Associate member state: Australia Who we are ~500 members of staff ~400 work in services & support >53 nationalities ~120 focus on basic research EMBL-EBI’s mission • Provide freely available data and bioinformatics services to all facets of the scientific community in ways that promote scientific progress • Contribute to the advancement of biology through basic investigator-driven research in bioinformatics • Provide advanced bioinformatics training to scientists at all levels, from PhD students to independent investigators • Help disseminate cutting-edge technologies to industry • Coordinate biological data provision throughout Europe Services Data and tools for molecular life science www.ebi.ac.uk/services Browse our services 9 What services do we provide? Labs around the
    [Show full text]
  • Functional Effects Detailed Research Plan
    GeCIP Detailed Research Plan Form Background The Genomics England Clinical Interpretation Partnership (GeCIP) brings together researchers, clinicians and trainees from both academia and the NHS to analyse, refine and make new discoveries from the data from the 100,000 Genomes Project. The aims of the partnerships are: 1. To optimise: • clinical data and sample collection • clinical reporting • data validation and interpretation. 2. To improve understanding of the implications of genomic findings and improve the accuracy and reliability of information fed back to patients. To add to knowledge of the genetic basis of disease. 3. To provide a sustainable thriving training environment. The initial wave of GeCIP domains was announced in June 2015 following a first round of applications in January 2015. On the 18th June 2015 we invited the inaugurated GeCIP domains to develop more detailed research plans working closely with Genomics England. These will be used to ensure that the plans are complimentary and add real value across the GeCIP portfolio and address the aims and objectives of the 100,000 Genomes Project. They will be shared with the MRC, Wellcome Trust, NIHR and Cancer Research UK as existing members of the GeCIP Board to give advance warning and manage funding requests to maximise the funds available to each domain. However, formal applications will then be required to be submitted to individual funders. They will allow Genomics England to plan shared core analyses and the required research and computing infrastructure to support the proposed research. They will also form the basis of assessment by the Project’s Access Review Committee, to permit access to data.
    [Show full text]
  • The ELIXIR Core Data Resources: ​Fundamental Infrastructure for The
    Supplementary Data: The ELIXIR Core Data Resources: fundamental infrastructure ​ for the life sciences The “Supporting Material” referred to within this Supplementary Data can be found in the Supporting.Material.CDR.infrastructure file, DOI: 10.5281/zenodo.2625247 (https://zenodo.org/record/2625247). ​ ​ Figure 1. Scale of the Core Data Resources Table S1. Data from which Figure 1 is derived: Year 2013 2014 2015 2016 2017 Data entries 765881651 997794559 1726529931 1853429002 2715599247 Monthly user/IP addresses 1700660 2109586 2413724 2502617 2867265 FTEs 270 292.65 295.65 289.7 311.2 Figure 1 includes data from the following Core Data Resources: ArrayExpress, BRENDA, CATH, ChEBI, ChEMBL, EGA, ENA, Ensembl, Ensembl Genomes, EuropePMC, HPA, IntAct /MINT , InterPro, PDBe, PRIDE, SILVA, STRING, UniProt ● Note that Ensembl’s compute infrastructure physically relocated in 2016, so “Users/IP address” data are not available for that year. In this case, the 2015 numbers were rolled forward to 2016. ● Note that STRING makes only minor releases in 2014 and 2016, in that the interactions are re-computed, but the number of “Data entries” remains unchanged. The major releases that change the number of “Data entries” happened in 2013 and 2015. So, for “Data entries” , the number for 2013 was rolled forward to 2014, and the number for 2015 was rolled forward to 2016. The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences ​ 1 Figure 2: Usage of Core Data Resources in research The following steps were taken: 1. API calls were run on open access full text articles in Europe PMC to identify articles that ​ ​ mention Core Data Resource by name or include specific data record accession numbers.
    [Show full text]
  • Easybuild Documentation Release 20210907.0
    EasyBuild Documentation Release 20210907.0 Ghent University Tue, 07 Sep 2021 08:55:41 Contents 1 What is EasyBuild? 3 2 Concepts and terminology 5 2.1 EasyBuild framework..........................................5 2.2 Easyblocks................................................6 2.3 Toolchains................................................7 2.3.1 system toolchain.......................................7 2.3.2 dummy toolchain (DEPRECATED) ..............................7 2.3.3 Common toolchains.......................................7 2.4 Easyconfig files..............................................7 2.5 Extensions................................................8 3 Typical workflow example: building and installing WRF9 3.1 Searching for available easyconfigs files.................................9 3.2 Getting an overview of planned installations.............................. 10 3.3 Installing a software stack........................................ 11 4 Getting started 13 4.1 Installing EasyBuild........................................... 13 4.1.1 Requirements.......................................... 14 4.1.2 Using pip to Install EasyBuild................................. 14 4.1.3 Installing EasyBuild with EasyBuild.............................. 17 4.1.4 Dependencies.......................................... 19 4.1.5 Sources............................................. 21 4.1.6 In case of installation issues. .................................. 22 4.2 Configuring EasyBuild.......................................... 22 4.2.1 Supported configuration
    [Show full text]
  • The 7Th White Coat Ceremony at SSPPS by Binh Tran, Pharmd
    The 7th White Coat Ceremony at SSPPS By Binh Tran, PharmD The White Coat Ceremony at the Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) on September 25th held special meaning as the University of California - San Diego celebrates its 50th Anniversary this year. SSPPS faculty, alumni, student pharmacists, the incoming class of 2014, their families and their friends listened to Dean Palmer Taylor’s welcoming address in the spacious Health Sciences auditorium modeled with panels made of eucalyptus wood. Dr Rita Shane, Director of Pharmacy Services at Cedars-Sinai Medical Center and Assistant Dean of Clinical Pharmacy at the UCSF School of Pharmacy delivered an energizing speech on The Power of Differentiation: Will you be a Brand or Generic? Attributes mentioned were competency, responsibility and accountability, intellectual curiosity, being able to seize opportunities, and establishing credibility. Dr. Anthony Manoguerra, Associate Dean for Student Affairs, reported that the class of 2014’s grade point average of 3.71 broke the record set by the previous class which averaged 3.70. The White Coat hooding by Dean Taylor was a moving ceremony with Justine Abella being last due to a recent foot injury. The class recited the Pharmacist’s Oath, which brought back memories of our own experiences. The Student Welcome by second- year student, Ammar Zanial, was heartfelt and reminiscent of his comments during pharmacy conference class. Little did I know at the time that the student pharmacist who volunteered at many outreaches in the community and helped backstage during Cultural Fusion Night was the President of his class. In closing, Dean Taylor commented on the ingeniousness of the class when he observed them tacitly move their seats in order to step closer to the stage.
    [Show full text]